Evidence map›Paper›PMID 26350270›Full record

ArticleRheumatology international2016

MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patients.

J F Mendoza Rincón, A K Rodríguez Elias, J M Fragoso, G Vargas Alarcón, K Maldonado Murillo, M L Rivas Jiménez, R E Barbosa Cobos, S Jimenez Morales, G Lugo Zamudio, C Tovilla Zárate and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Functional polymorphisms inOncotarget · 2017
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

J F Mendoza RincónLaboratorio de Oncología Molecular, Unidad de Diferenciación Celular y Cáncer, FES-Zaragoza, UNAM, Mexico City, Mexico.
A K Rodríguez EliasPrograma de Maestría en Biología Experimental, UAM-I, México City, Mexico.
J M FragosoDepartamento de Biología Molecular, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
G Vargas AlarcónDepartamento de Biología Molecular, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
K Maldonado MurilloLicenciatura en Biología, Facultad de Estudios Superiores, Zaragoza, UNAM, Mexico City, Mexico.
M L Rivas JiménezServicio de Reumatología, Hospital Lic. Adolfo López Mateos, Mexico City, Mexico.
R E Barbosa CobosServicio de Reumatología, Hospital Juárez de México, Mexico City, Mexico.
S Jimenez MoralesDirección de Investigación, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
G Lugo ZamudioDivisión de Medicina, Hospital Juárez de México, Mexico City, Mexico.
C Tovilla ZárateDivisión Académica Multidisciplinaria de Comalcalco, Universidad Juárez Autónoma de Tabasco, Comalcalco, Tabasco, Mexico.
J Ramírez BelloLaboratorio de Medicina Genómica, Unidad de Investigación, Hospital Juárez de México, Av. Instituto Politécnico Nacional No. 5160, Delegación Gustavo A. Madero, C.P. 07760, Mexico City, D.F, Mexico. dr.julian.ramirez.hjm@gmail.com.ORCID http://orcid.org/0000-0002-4153-9315
Hospital Juárez de México · MXInstituto Nacional de Cardiología · MXCentro de Estudios Universitarios Adolfo López Mateos · MXNational Institute of Genomic Medicine · MXUniversidad Juárez Autónoma de Tabasco · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a multifactorial disease. A combination of genetic and environmental risk factors contributes to its etiology. Several genes have been reported to be associated with susceptibility to the development of RA. The MHC2TA and FCRL3 genes have been associated previously with RA in Swedish and Japanese populations, respectively. In two recent reports, we show an association between FCRL3 and juvenile rheumatoid arthritis (JRA), and MHC2TA and acute coronary syndrome (ACS) in Mexican population. We assessed the association between three single nucleotide polymorphisms (SNPs) of the MHC2TA (-168G/A; rs3087456, and +16G/C; rs4774) and FCRL3 (-169T/C; rs7528684) genes and rheumatoid arthritis in Mexican population through a genotyping method using allelic discrimination assays with TaqMan probes. Our case-control study included 249 patients with RA and 314 controls. We found no evidence of an association between the MHC2TA -168G/A and +1614G/C or FCRL3 -169T/C polymorphisms and RA in this Mexican population. In this cohort of Mexican patients with RA, we observed no association between the MHC2TA or FCRL3 genes and this autoimmune disease.

Indexed as

Polymorphism, Single NucleotideAdultArthritis, RheumatoidCase-Control StudiesFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHaplotypesHumansMaleMexicoMiddle AgedNuclear ProteinsPhenotypeReceptors, ImmunologicFCRL3 protein, humanMHC class II transactivator proteinNuclear ProteinsReceptors, ImmunologicTrans-ActivatorsFCRL3MHC2TAPolymorphismRheumatoid arthritis

Identifiers

PMID26350270
OpenAlexW2172820075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.